MRI scans more precisely define and detect some abnormalities in unborn babies

17 Mar 2021, 10:57 a.m.

MRI scan of fetus

MRI scanning can more precisely define and detect head, neck, thoracic, abdominal and spinal malformations in unborn babies, finds a large multidisciplinary study led by Evelina London Children’s Hospital, Great Ormond Street Hospital and UCL.

In the study, published today in Lancet Child and Adolescent Health, the team of researchers and clinicians demonstrate the ways that MRI scanning can show malformations in great detail, including their effect on surrounding structures. Importantly, they note that MRI is a very safe procedure for pregnant women and their babies.

They say the work, is invaluable both to clinicians caring for babies before they are born and for teams planning care of the baby after delivery.

Images courtesy of Alena Uus and Maria Deprez

Recent research has concentrated on correcting for fetal movement in fetal brain MRI and, more recently, for imaging the developing heart. However, there is an increasing demand to assess the entire fetus with MRI and research from the School of Biomedical Engineering & Imaging Sciences at Evelina London Children’s Hospital (BMEIS), have recently been able to develop a method to refine and correct the images captured, of the whole fetal body, even if there is movement during the scan.

Professor Paolo De Coppi, Consultant Paediatric Surgeon at GOSH and collaborator in the research said:

“For most expectant parents, an ultrasound is all that is needed to check on the health of their baby, but MRI is a safe option to give us more detail when we need to further investigate the growing fetus. For example, fetal MRI is an invaluable tool to assess spina bifida before birth - imaging of the fetal brain along with the spinal cord is an important factor in evaluating who could benefit from fetal surgery – so any advances in the technology are a welcome step forward.”

MRI can give more precise information than ultrasound alone

Lead researcher, Professor Mary Rutherford said ultrasound remains the gold standard for fetal screening and indeed is complementary to these optimized MRI approaches for evaluating abnormalities of the fetal body.

“Until now, ultrasound has been the modality of choice to diagnose those anomalies. However, sometimes the ability of ultrasound to define the most detailed anatomy is limited. MRI scanning offers the potential to more precisely define malformations that could help support clinicians in their planning of care and counselling of parents,”.

MRI is commonly used in the classification of fetal brain anomalies, although its use in fetal body anomalies is less widely adopted, advances have led to the validation of its role in the antenatal investigation of several conditions including the investigation of fetuses with spina bifida: imaging of the fetal brain along with the spinal cord is an important factor in evaluating which patients could benefit from fetal surgery.

For fetal neck masses, MRI provides a clear advantage over conventional ultrasound for assessing tumour extension and giving a 3D visualisation of the tumour’s relation to the airway.

MRI may also be better than ultrasound for distinguishing between normal and abnormal lung tissue, and in making other diagnoses such as diaphragmatic hernia—particularly in late gestation, when doing so with ultrasound is challenging.

New approaches to imaging the fetal body with MRI allows both motion correction of the fetal images and volume reconstructions of body organs and defects. Researchers say this improves visualisation and therefore detection and characterisation of abnormalities.

The project brought together surgeons, fetal medicine specialists, radiologists and physicists to review the use of magnetic resonance imaging to investigate conditions in the unborn baby; this approach has already been integrated into clinical practice at Guy's and St Thomas' Trust.

Ongoing work is focused on a fully automated process suitable for clinical translation and wider dissemination into clinical practice.

Fetal body MRI and its application to fetal and neonatal treatment: an illustrative review, Davidson et al, The Lancet Child & Adolescent Health, Available online 12 March 2021

Images courtesy of Alena Uus and Maria Deprez.

All research at GOSH is unperpinned by the NIHR GOSH BRC

Common inflammatory bowel disease treatment is linked to reduced COVID-19 antibody response

New evidence indicates the commonly-prescribed inflammatory bowel disease (IBD) drug infliximab blunts the immune system to COVID-19 infection, potentially increasing the risk of reinfection.

GOSH and UCL researchers receive funding to improve outcomes for children and young people with cancer

Researchers at University College London and Great Ormond Street Hospital receive £1.7m of grants in new Cancer Research UK-Children with Cancer UK Innovation Awards.

Cellular benefits of gene therapy seen decades after treatment

An international collaboration has shown the beneficial effects of gene therapy can be seen decades after the transplanted blood stem cells have been cleared by the body.

GOSH and Moorfields treat the UK’s youngest patient with sight-saving gene therapy

Three year old Leo and his family appear in BBC 2's DNA Family Secrets to share their journey for answers into his condition and his successful treatment with Voretigene Neparvovec